News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
309,532 Results
Type
Article (15901)
Company Profile (317)
Press Release (293307)
Multimedia
Podcasts (78)
Webinars (13)
Section
Business (87189)
Career Advice (289)
Deals (14992)
Drug Delivery (42)
Drug Development (51522)
Employer Resources (43)
FDA (6327)
Job Trends (6067)
News (155826)
Policy (10828)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1090)
Accelerated approval (19)
Adcomms (14)
Allergies (83)
Alliances (24621)
ALS (133)
Alzheimer's disease (1065)
Antibody-drug conjugate (ADC) (244)
Approvals (6532)
Artificial intelligence (319)
Autoimmune disease (113)
Automation (12)
Bankruptcy (110)
Best Places to Work (5364)
BIOSECURE Act (7)
Biosimilars (107)
Biotechnology (240)
Bladder cancer (103)
Brain cancer (47)
Breast cancer (377)
Cancer (3313)
Cardiovascular disease (261)
Career advice (259)
Career pathing (8)
CAR-T (222)
CDC (5)
Cell therapy (589)
Cervical cancer (15)
Clinical research (44365)
Collaboration (1314)
Company closure (2)
Compensation (594)
Complete response letters (39)
COVID-19 (1157)
CRISPR (90)
C-suite (577)
Cystic fibrosis (118)
Data (4446)
Denatured (15)
Depression (96)
Diabetes (280)
Diagnostics (1901)
Digital health (16)
Diversity (5)
Diversity, equity & inclusion (10)
Drug discovery (204)
Drug pricing (55)
Drug shortages (3)
Duchenne muscular dystrophy (216)
Earnings (33865)
Editorial (28)
Employer branding (6)
Employer resources (36)
Events (55217)
Executive appointments (669)
FDA (8195)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (1066)
Gene editing (190)
Generative AI (24)
Gene therapy (505)
GLP-1 (548)
Government (1290)
Grass and pollen (3)
Guidances (190)
Healthcare (7686)
HIV (27)
Huntington's disease (43)
IgA nephropathy (75)
Immunology and inflammation (196)
Immuno-oncology (41)
Indications (67)
Infectious disease (1276)
Inflammatory bowel disease (159)
Inflation Reduction Act (10)
Influenza (44)
Intellectual property (171)
Interviews (40)
IPO (8316)
IRA (14)
Job creations (1006)
Job search strategy (225)
JPM (43)
Kidney cancer (9)
Labor market (24)
Layoffs (248)
Leadership (9)
Legal (1564)
Liver cancer (42)
Longevity (13)
Lung cancer (442)
Lymphoma (256)
Machine learning (25)
Management (11)
Manufacturing (428)
MASH (132)
Medical device (3728)
Medtech (3739)
Mergers & acquisitions (7385)
Metabolic disorders (778)
Multiple sclerosis (107)
NASH (14)
Neurodegenerative disease (235)
Neuropsychiatric disorders (71)
Neuroscience (2012)
Neurotech (1)
NextGen: Class of 2026 (2442)
Non-profit (1213)
Now hiring (30)
Obesity (357)
Opinion (138)
Ovarian cancer (136)
Pain (105)
Pancreatic cancer (168)
Parkinson's disease (236)
Partnered (19)
Patents (307)
Patient recruitment (337)
Peanut (43)
People (28475)
Pharmaceutical (49)
Pharmacy benefit managers (7)
Phase 1 (15676)
Phase 2 (20532)
Phase 3 (13123)
Pipeline (3410)
Policy (100)
Postmarket research (883)
Preclinical (6629)
Press Release (35)
Prostate cancer (153)
Psychedelics (50)
Radiopharmaceuticals (245)
Rare diseases (663)
Real estate (1900)
Recruiting (16)
Regulatory (10469)
Reports (21)
Research institute (1188)
Resumes & cover letters (37)
Rett syndrome (24)
RNA editing (21)
RSV (21)
Schizophrenia (125)
Series A (201)
Series B (142)
Service/supplier (1)
Sickle cell disease (78)
Special edition (18)
Spinal muscular atrophy (121)
Sponsored (19)
Startups (2121)
State (1)
Stomach cancer (5)
Supply chain (40)
Tariffs (20)
The Weekly (62)
Vaccines (364)
Venture capital (73)
Weight loss (192)
Women's health (28)
Worklife (2)
Date
Last 7 days (363)
Last 30 days (1263)
Last 365 days (19046)
2026 (1733)
2025 (19444)
2024 (22235)
2023 (24071)
2022 (29876)
2021 (30062)
2020 (25802)
2019 (18776)
2018 (13576)
2017 (15139)
2016 (13125)
2015 (15810)
2014 (11377)
2013 (8362)
2012 (8437)
2011 (8598)
2010 (8076)
Location
Africa (201)
Alabama (73)
Alaska (3)
Arizona (80)
Arkansas (7)
Asia (20125)
Australia (3314)
California (7511)
Canada (1977)
China (826)
Colorado (265)
Connecticut (266)
Delaware (239)
Europe (42383)
Florida (1013)
Georgia (216)
Hawaii (2)
Idaho (18)
Illinois (467)
India (39)
Indiana (195)
Iowa (11)
Japan (243)
Kansas (86)
Kentucky (11)
Louisiana (10)
Maine (13)
Maryland (791)
Massachusetts (5811)
Michigan (123)
Minnesota (292)
Mississippi (5)
Missouri (42)
Montana (20)
Nebraska (7)
Nevada (47)
New Hampshire (29)
New Jersey (1823)
New Mexico (15)
New York (1878)
North Carolina (906)
North Dakota (7)
Northern California (3672)
Ohio (191)
Oklahoma (12)
Oregon (25)
Pennsylvania (1373)
Puerto Rico (10)
Rhode Island (31)
South America (264)
South Carolina (11)
Southern California (2975)
Tennessee (64)
Texas (982)
United States (25031)
Utah (113)
Virginia (155)
Washington D.C. (41)
Washington State (619)
West Virginia (2)
Wisconsin (56)
Wyoming (1)
309,532 Results for "edge therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy
December 25, 2025
·
11 min read
Press Releases
Fujifilm to Highlight Cutting-Edge Imaging Innovations at RSNA 2025
November 26, 2025
·
4 min read
Press Releases
Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026
January 13, 2026
·
9 min read
Press Releases
ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand
Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler spending on data centers, and rapid growth in behind-the-meter energy storage solutions
October 1, 2025
·
5 min read
Press Releases
Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026
February 5, 2026
·
1 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Fosun Marks Eighth Year at CIIE, Guo Guangchang Calls for More Cutting-Edge Innovation
November 6, 2025
·
8 min read
Press Releases
Edgewise Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
January 6, 2026
·
1 min read
Drug Development
Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced the dosing of the first patient in the Phase 2 CIRRUS-HCM trial of EDG-7500.
May 6, 2024
·
8 min read
Press Releases
Breakthrough Properties Completes One Helix, A Cutting-edge Research Facility Fully Leased to AstraZeneca
November 5, 2025
·
4 min read
1 of 30,954
Next